About Ahn-Gook Pharmaceutical
Ahn-Gook Pharmaceutical is a publicly listed company based in Seoul (South Korea) founded in 1955. Pharmaceutical products. The company has 420 employees. Its chief executive, as recorded, is Jin Auh. Its website ahn-gook.com draws about 26 thousand monthly visits. Its focus areas include Pharmaceutical Distributors and Diversified. Its competitors include Taejeon Group and Nexus Pharma.
Company details
Ahngook Pharm is engaged in manufacturing and marketing of pharmaceutical products. Products offered include Tobicom S, Sinecura syrup, Annecor capsules, levotensin tablets, digestive system, osteoarthritis, etc.
- Headquarters Seoul, South Korea
- Employees 420
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website ahn-gook.com
- Social LinkedIn X
- Legal Name Ahn-Gook Pharmaceutical Co., Ltd.
- Annual Revenue$212.48 M (USD)13.19as on Dec 31, 2025
- Net Profit$5.18 M (USD)-55.59as on Dec 31, 2025
- EBITDA$12.87 M (USD)29.8as on Dec 31, 2025
- Investors
- Employee Count420
Funding Insights of Ahn-Gook Pharmaceutical
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Ahn-Gook Pharmaceutical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2011 | Post-IPO | – | – |
1 investors in total: 1 institutional.
Investors in Ahn-Gook Pharmaceutical
Ahn-Gook Pharmaceutical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Lindeman Asia Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of a venture capital and private equity investing across multiple sectors | 2000 | laic.kr | Seoul, South Korea |
Investor details for Ahn-Gook Pharmaceutical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ahn-Gook Pharmaceutical
2 people are tracked at Ahn-Gook Pharmaceutical (2 in leadership); the tracked headcount is 420.
| Name | Role | Group |
|---|---|---|
Jin Auh | Co-CEO | Leadership |
Joon Sun Auh | Co-CEO | Leadership |
Complete people profiles for Ahn-Gook Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Ahn-Gook Pharmaceutical
Ahn-Gook Pharmaceutical is a publicly listed company on the KRX with ticker symbol 001540 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Jun 2000
- Listed onKRX: 001540
- Listed entityAHN-GOOK PHARMACEUTICAL Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7001540004
- Share price9,850.00 KRW (-0.61% on the day) · 2026-10-14
- Market capitalisation112,630,767,431.00 KRW
- Price to earnings5.2
- EPS (diluted, trailing year)1,905.21 KRW
- Dividend yield6.39%
- Volume (last session)15,102
Financials of Ahn-Gook Pharmaceutical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 306.87B KRW | 7.48B KRW | 18.58B KRW |
| 2024 | 271.12B KRW | 16.85B KRW | 14.31B KRW |
| 2023 | 233.68B KRW | 1.29B KRW | 9.55B KRW |
| 2022 | 205.39B KRW | 6.88B KRW | 13.69B KRW |
| 2021 | 163.53B KRW | 3.94B KRW | 3.42B KRW |
Detailed financial statements for Ahn-Gook Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Ahn-Gook Pharmaceutical
3 dated milestones of Ahn-Gook Pharmaceutical across 56 years, from founding to its latest funding, stage changes and deals.
- Founded Ahn-Gook Pharmaceutical is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round.
Competitors of Ahn-Gook Pharmaceutical
Ahn-Gook Pharmaceutical has 2 listed competitors in our database. They include Taejeon Group and Nexus Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| taejeongroup.com | 1935 | Jeonju, South Korea | Distributes a variety of pharmaceutical drugs. | |||
| nexus-pharma.com | 2015 | Seoul, South Korea | Manufactures pharmaceuticals, cosmeceuticals, skincare, and distributes globally to partners and clinics. |
Detailed competitors of Ahn-Gook Pharmaceutical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ahn-Gook Pharmaceutical
The website of Ahn-Gook Pharmaceutical (ahn-gook.com) receives about 25.7K visits a month and ranks #653,877 among all websites worldwide, #725 in Biotechnology and Pharmaceuticals.
- Monthly visits25.7K
▲ 45.9% vs previous month
- Unique visitors5.6K
per month
- Global rank#653,877
among all websites
- Category rank#725
Health · Biotechnology and Pharmaceuticals
- Bounce rate36%
- Pages per visit19.8
- Average visit10 min 28 sec
- DevicesDesktop 72% · Mobile 28%
Websites whose visitors overlap most with Ahn-Gook Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ahngookpharmaceuti.lookchem.com | ahngookpharmaceuti.lookchem.com | 100% | – | ||
| cjp.co.kr | 100% | View details | |||
| celltrion.com | 100% | 179.3K | #287,455 | View details | |
no1health2.or.kr | no1health2.or.kr | 96% | #3,103,181 | – | |
| rpskorea.com | 61% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Ahn-Gook Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ahn-Gook Pharmaceutical
Complete news archive for Ahn-Gook Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ahn-Gook Pharmaceutical
Ahn-Gook Pharmaceutical was founded in 1955 and raised its 1st funding round 56 years after it was founded.
Ahn-Gook Pharmaceutical is headquartered in Seoul, South Korea.
Jin Auh is the CEO of Ahn-Gook Pharmaceutical, as recorded in our data.
Ahn-Gook Pharmaceutical has 420 employees.
Annual revenue of Ahn-Gook Pharmaceutical is $212.48M as on Dec 31, 2025.
Ahngook Pharm is engaged in manufacturing and marketing of pharmaceutical products. Products offered include Tobicom S, Sinecura syrup, Annecor capsules, levotensin tablets, digestive system, osteoarthritis, etc.
Ahn-Gook Pharmaceutical's top competitors include Taejeon Group and Nexus Pharma.
Yes, Ahn-Gook Pharmaceutical is publicly traded on KRX under the ticker symbol 001540.
Ahn-Gook Pharmaceutical has 1 investor. Key investors include Lindeman Asia Investment.